Procyon Advisors
LLY icon

Procyon Advisors’s Eli Lilly LLY Stock Holding History

Procyon Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.22M Buy
7,105
+697
+11% +$822K 0.35% 63
2026
Q2 		$7.69M Sell
6,408
-691
-10% -$706K 0.33% 69
2026
Q1 		$6.53M Sell
7,099
-128
-2% -$130K 0.32% 70
2025
Q4 		$7.77M Buy
7,227
+4,616
+177% +$4.41M 0.38% 59
2025
Q3 		$1.99M Buy
2,611
+35
+1% +$26K 0.12% 143
2025
Q2 		$2.01M Sell
2,576
-1,659
-39% -$1.29M 0.19% 104
2025
Q1 		$3.5M Buy
4,235
+293
+7% +$244K 0.21% 104
2024
Q4 		$3.04M Buy
3,942
+419
+12% +$347K 0.19% 113
2024
Q3 		$3.12M Sell
3,523
-82
-2% -$73.7K 0.21% 102
2024
Q2 		$3.26M Buy
3,605
+12
+0.3% +$9.6K 0.24% 95
2024
Q1 		$2.8M Sell
3,593
-231
-6% -$164K 0.22% 110
2023
Q4 		$2.23M Buy
3,824
+514
+16% +$300K 0.19% 126
2023
Q3 		$1.78M Buy
3,310
+888
+37% +$458K 0.18% 129
2023
Q2 		$1.14M Buy
2,422
+100
+4% +$41.9K 0.14% 152
2023
Q1 		$797K Buy
2,322
+228
+11% +$76.9K 0.13% 155
2022
Q4 		$766K Buy
2,094
+760
+57% +$269K 0.14% 150
2022
Q3 		$431K Sell
1,334
-308
-19% -$97.6K 0.11% 186
2022
Q2 		$532K Buy
1,642
+20
+1% +$6K 0.12% 170
2022
Q1 		$464K Sell
1,622
-308
-16% -$79.3K 0.1% 199
2021
Q4 		$533K Sell
1,930
-96
-5% -$24.3K 0.11% 169
2021
Q3 		$468K Buy
2,026
+20
+1% +$4.94K 0.12% 167
2021
Q2 		$460K Buy
2,006
+75
+4% +$15.1K 0.13% 153
2021
Q1 		$361K Sell
1,931
-1
-0.1% -$196 0.16% 149
2020
Q4 		$326K Sell
1,932
-275
-12% -$41.1K 0.16% 151
2020
Q3 		$327K Buy
2,207
+62
+3% +$9.6K 0.18% 128
2020
Q2 		$352K Sell
2,145
-218
-9% -$33.5K 0.19% 112
2020
Q1 		$328K Buy
2,363
+118
+5% +$16.2K 0.22% 97
2019
Q4 		$295K Buy
+2,245
New +$260K 0.18% 115

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Procyon Advisors's LLY Position: Q3 2026 in Review

Procyon Advisors increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $822K and bringing the position to 7,105 shares worth $8.22M. The position accounts for 0.35% of the portfolio, ranked #63.

Procyon Advisors first reported a position in LLY in Q4 2019 and has held it in 28 quarters since. 2,535 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Procyon Advisors held 7,105 shares of Eli Lilly worth $8.22M as of Q3 2026.
  • Procyon Advisors bought 697 Eli Lilly shares in Q3 2026, an estimated $822K.
  • Eli Lilly made up 0.35% of Procyon Advisors's portfolio in Q3 2026, its #63 holding.
  • Procyon Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 28 quarters since.
  • 2,535 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Procyon Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.